Nicholette Zeliadt
@nzeliadt.bsky.social
Managing Editor at The Transmitter, a publication for the neuroscience community thetransmitter.org @thetransmitter.bsky.social
Reposted by Nicholette Zeliadt
@thetransmitter.bsky.social presents a portrait of the state of neuroscience in 2025 through four lenses: its focus, its output, its people and its funding. Each view features analyses of major trends and more. Explore the end of year report: bit.ly/4oNeTVC
#neuroskyence #StateofNeuro
#neuroskyence #StateofNeuro
November 15, 2025 at 3:37 PM
@thetransmitter.bsky.social presents a portrait of the state of neuroscience in 2025 through four lenses: its focus, its output, its people and its funding. Each view features analyses of major trends and more. Explore the end of year report: bit.ly/4oNeTVC
#neuroskyence #StateofNeuro
#neuroskyence #StateofNeuro
Reposted by Nicholette Zeliadt
The FDA wants to expand the use of leucovorin to treat autism traits, based on an analysis of the scientific research. @thetransmitter.bsky.social has obtained the list of 23 studies.
By @claudia-lopez.bsky.social
www.thetransmitter.org/spectrum/exc...
By @claudia-lopez.bsky.social
www.thetransmitter.org/spectrum/exc...
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
www.thetransmitter.org
October 3, 2025 at 2:05 PM
The FDA wants to expand the use of leucovorin to treat autism traits, based on an analysis of the scientific research. @thetransmitter.bsky.social has obtained the list of 23 studies.
By @claudia-lopez.bsky.social
www.thetransmitter.org/spectrum/exc...
By @claudia-lopez.bsky.social
www.thetransmitter.org/spectrum/exc...
Reposted by Nicholette Zeliadt
“I breathed a sigh of relief when I saw that the list did not include multiple studies on why vaccines cause autism,” says Brian Lee about the newly awarded Autism Data Science Initiative projects.
By @callimcflurry.bsky.social
#neuroskyence
www.thetransmitter.org/spectrum/exc...
By @callimcflurry.bsky.social
#neuroskyence
www.thetransmitter.org/spectrum/exc...
Autism researchers remain concerned about NIH data project
An atypical funding mechanism, short timeline and opaque review process had generated concern over the quality of projects that would be selected.
www.thetransmitter.org
October 2, 2025 at 6:54 PM
“I breathed a sigh of relief when I saw that the list did not include multiple studies on why vaccines cause autism,” says Brian Lee about the newly awarded Autism Data Science Initiative projects.
By @callimcflurry.bsky.social
#neuroskyence
www.thetransmitter.org/spectrum/exc...
By @callimcflurry.bsky.social
#neuroskyence
www.thetransmitter.org/spectrum/exc...
Reposted by Nicholette Zeliadt
The NIH has spent nearly its entire budget for this fiscal year, but the number of new grants has dropped compared with past years.
By Natalia Mesa
#neuroskyence
www.thetransmitter.org/funding/nih-...
By Natalia Mesa
#neuroskyence
www.thetransmitter.org/funding/nih-...
NIH awarded 37 percent fewer neuroscience-related grants in 2025 than in past years
But the agency has spent nearly its entire budget for this fiscal year, which ends tomorrow.
www.thetransmitter.org
October 2, 2025 at 4:54 PM
The NIH has spent nearly its entire budget for this fiscal year, but the number of new grants has dropped compared with past years.
By Natalia Mesa
#neuroskyence
www.thetransmitter.org/funding/nih-...
By Natalia Mesa
#neuroskyence
www.thetransmitter.org/funding/nih-...
Reposted by Nicholette Zeliadt
Meet Richard Frye, whose research record on leucovorin traces the gulf between promise and proof.
By Brendan Borrell
www.thetransmitter.org/spectrum/exc...
By Brendan Borrell
www.thetransmitter.org/spectrum/exc...
Exclusive: Meet Richard Frye, who studies leucovorin for autism
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
www.thetransmitter.org
October 1, 2025 at 9:29 PM
Meet Richard Frye, whose research record on leucovorin traces the gulf between promise and proof.
By Brendan Borrell
www.thetransmitter.org/spectrum/exc...
By Brendan Borrell
www.thetransmitter.org/spectrum/exc...
Reposted by Nicholette Zeliadt
Exclusive from The Transmitter: Howard Hughes Medical Institute (HHMI) to limit eligible universities for Investigator Program in bid to spread the wealth:
www.thetransmitter.org/funding/howa...
By @shaena.bsky.social
www.thetransmitter.org/funding/howa...
By @shaena.bsky.social
Howard Hughes Medical Institute to limit eligible universities for Investigator Program in bid to spread the wealth
The next round of competition, slated for late 2025, will have a new focus, according to an HHMI spokesperson.
www.thetransmitter.org
December 7, 2024 at 12:50 PM
Exclusive from The Transmitter: Howard Hughes Medical Institute (HHMI) to limit eligible universities for Investigator Program in bid to spread the wealth:
www.thetransmitter.org/funding/howa...
By @shaena.bsky.social
www.thetransmitter.org/funding/howa...
By @shaena.bsky.social
Reposted by Nicholette Zeliadt
Neuroscientists are flocking to Bluesky, but X still has ten times more users. My story on the migration, featuring @nicolecrust.bsky.social @russpoldrack.bsky.social @charan-neuro.bsky.social @therealdrdukes.bsky.social @wiringthebrain.bsky.social + more! www.thetransmitter.org/community/hu...
‘Huge influx’ of neuroscientists migrates to Bluesky
Daily neuroscience-related posts on the social-media platform this week have increased more than 400 percent, on average, compared with October.
www.thetransmitter.org
November 21, 2024 at 5:14 PM
Neuroscientists are flocking to Bluesky, but X still has ten times more users. My story on the migration, featuring @nicolecrust.bsky.social @russpoldrack.bsky.social @charan-neuro.bsky.social @therealdrdukes.bsky.social @wiringthebrain.bsky.social + more! www.thetransmitter.org/community/hu...